Fibroscan Doctors Abroad — Page 2

Dr. Hasan Mutlu is a medical oncologist at Medical Park Antalya Hospital Complex. He specializes in immunotherapy, targeted cancer therapies, and genetic research in cancer treatment. Dr. Mutlu received his medical degree from Hacettepe University. He holds the title of Professor of Medicine. Dr. Mutlu focuses on organ tumor diagnosis and chemotherapy.

• Specializes in both medical and pediatric oncology cases.
• Treats complex conditions including neuroblastoma, Wilms tumor, and Ewing's sarcoma.
• Performs biological therapies and stays active in next-generation genetic research.
• Works at the Mediterranean region’s largest private hospital with PET-CT and LINAC technology.

Dr. Yasar Tuna is a gastroenterologist and gastrointestinal surgeon at Medical Park Antalya Hospital Complex. He specializes in the treatment of complex digestive conditions and bariatric surgery. Dr. Tuna performs procedures at a facility that houses one of Turkey's premier organ transplant centers.

• Treats chronic conditions including Crohn's disease, ulcerative colitis, and cirrhosis.
• Performs bariatric procedures such as gastric sleeve, gastric bypass, and gastric balloon.
• Member of the Turkish Society of Gastroenterology and the Endoscopy Association.
• Works at a facility that performs the most successful transplants in Turkey.

Dr. Viktor Alexander Krol is the Chief Physician of Gastroenterology and Internal Medicine at St. Martinus-Krankenhaus Düsseldorf. He also directs a certified Obesity Treatment Center. Dr. Krol treats complex diseases of the digestive tract, metabolism, and respiratory system. He works at one of only two German clinics accredited by the International Federation of Obesity.

• Performs bariatric surgeries and endoscopic weight loss procedures.
• Treats gastrointestinal conditions like pancreatitis, Crohn's disease, and cirrhosis.
• Manages internal medicine cases across cardiology, diabetology, and nephrology.
• Uses diagnostic tools including gastroscopy with biopsy and endosonography.

Dr. Peter Schenker is the Chief Surgeon at the Medical Center in Solingen. He specializes in gastrointestinal oncology and pancreatic surgery. He formerly served as the Chief Surgeon at Germany’s first certified colorectal cancer center. Dr. Schenker focuses on robotic and minimally invasive surgical methods. He treats complex conditions like Barrett's esophagus and Crohn's disease.

• Chief Surgeon of the Department of Surgery at the Academic Hospital Solingen.
• Served as the Coordinator of the Pancreatic Cancer Center (Oncocert).
• Member of the German Medical Association and scientific journal expert.
• Specializes in hernia surgery and pancreatic transplantation.

Dr. Cheon Wonseok is Head of Gastroenterology at Na-Eun Hospital. He treats gastrointestinal disorders. He performs upper endoscopy, colonoscopy, polypectomy, and ESD. He manages gastric and esophageal cancer and Helicobacter pylori infection. He also treats liver disease and inflammatory bowel disease, including Crohn’s disease and ulcerative colitis. He offers small-bowel capsule endoscopy.

Accreditations: Board-certified specialist in gastrointestinal endoscopy. Lifetime member, Korean Society of Gastrointestinal Endoscopy. Full member, Korean Association of Internal Medicine.

Training: Kyung Hee University College of Medicine. Internship, Kyung Hee University Medical Center. Residency in internal medicine, Hallym University Sacred Heart Hospital. Clinical fellowship in gastroenterology, Chung-Ang University Hospital.

Dr. Omer Burcak Binicier is a gastroenterologist at Medicalpoint International Hospital in Izmir. He focuses on early-stage gastrointestinal cancers and inflammatory bowel diseases. Dr. Binicier completed international training at the Korea University Faculty of Medicine. He treats complex liver, pancreatic, and digestive system disorders using manual and robotic-assisted techniques.

• Performs therapeutic endoscopy including EMR, ESD, and ERCP.
• Provides minimally invasive obesity treatments like intragastric balloons.
• Expert in endoscopic ultrasound for precise digestive tract imaging.
• Practices at JCI-accredited Medicalpoint International Hospital.

Dr. Muhammed Mustafa Atci is an Associate Professor of Medical Oncology at Liv Hospital Topkapı. He specializes in treating colon, breast, gastric, and lung cancers. He previously served as the Education Coordinator at Prof. Dr. Cemil Taşcıoğlu City Hospital. Dr. Atci is a member of the American Society of Clinical Oncology (ASCO).

• Author of 19 peer-reviewed papers on gastrointestinal, thoracic, and endocrine cancers.
• Published studies on survival outcomes for stage IIB colon cancer in the Journal of Chemotherapy.
• Researches prognostic biomarkers using PET/CT scans and metabolic tumor volume.
• Treats complex oncological cases at the university-affiliated İstinye University clinic.

Dr. Selin Kapan is a general surgery professor at İstinye University Liv Hospital Topkapı. She specializes in gastrointestinal surgery and laparoscopic hernia repair. Dr. Kapan has published over 50 peer-reviewed papers in international medical journals. Her research focuses on perianal fistulas and hepatic hydatid disease.

• Performs bariatric procedures including gastric sleeve and bypass surgeries.
• Expert in hernia repair using laparoscopic and robotic techniques.
• Treats complex conditions like salivary gland tumors and pilonidal disease.
• Is a member of the Turkish Surgical Association and the Hernia Society.

Dr. Seymur Aslanov is a gastroenterologist at Medicalpoint International Hospital in İzmir. He completed his subspecialty training at Ege University. Dr. Aslanov treats inflammatory bowel diseases, liver disorders, and digestive system cancers. He is a member of the Izmir Medical Chamber.

• Performs ERCP and endoscopic procedures to treat biliary tract diseases.
• Treats Crohn's disease and ulcerative colitis using stem cell therapy.
• Surgical expertise includes endoscopic polypectomy and stenting for gastrointestinal stenosis.
• Works at a JCI-accredited hospital with ISO and TEMOS quality certifications.

Dr. Sanchez Yague is a gastroenterologist at Quirónsalud Marbella in Spain. He was the first professional globally to use the 15-mm AXIOS stent. This device drains pancreatic fluid collections. He pioneered submucosal endoscopic dissection in Spain. Dr. Sanchez Yague also introduced gastroenteroanastomosis with luminal apposition stents to Andalusia.

• Fellow of the American College of Gastroenterology (FACG).
• Fellow of the American Society for Gastrointestinal Endoscopy (FASGE).
• Coauthored European Society of Gastrointestinal Endoscopy guides on chronic pancreatitis.
• Winner of the Top Reviewer Award from the Gastrointestinal Endoscopy Journal.

Professor Lee Seok-gu is a leading liver transplant surgeon at Myongji Hospital. He has performed about 2,000 liver transplants. He achieved Korea’s first transfusion-free liver transplant. He performed hepatocyte transplantation in a one-month-old infant. He led the first clinical use of a bioartificial liver for acute liver failure. He also performed living-donor transplants in Egypt and trained teams in Vietnam.

He is Professor of Surgery at Myongji Hospital and former Director of the Organ Transplantation Center at Samsung Medical Center. He earned his MD and MSc from Seoul National University and his PhD from the Catholic University of Korea. He completed a fellowship at Boston Children’s Hospital/Harvard and transplant training at Johns Hopkins. He served as president of three national societies in transplantation and pediatric surgery. His honors include the Chong Kun Dang Award, the Pfizer Clinical Medicine Award, and the Astellas Investigator Award. He has 447 publications and 13 book chapters.

Dr. Lopez-jamar is a pioneer in digestive imaging and heads the Endoscopy Unit at Hospital Ruber Internacional. He uses advanced technologies like Fibroscan to assess liver health without invasive biopsies.

• Heads the Digestive Diseases Unit at one of Spain's top hospitals
• Pioneered endoscopic ultrasound techniques for precise gastrointestinal diagnosis
• Participates in multicenter European studies on diagnostic technologies
• Member of the European Society of Gastrointestinal Endoscopy
• PhD in Medicine and Surgery from Complutense University of Madrid

Zhang Jinshan, male, China’s First M.D. in the Radiation Medicine, CCI (Chinese College of Interventionalists) Master Interventionalist, Director of the Department of Former Radiological Diagnosis at Chinese PLA General Hospital(No.3 in China) Ph.D. of Medicine, Nagasaki University, Japan.

1980–1985: Completed doctoral studies at Nagasaki University, Japan

1968–present: Department of Radiology, Chinese PLA General Hospital

1988: Third Prize of the Military Science and Technology Progress Award

1989–present: Member of Radiological Society of North America(RSNA)

1990–2009: Standing Committee Member of the Radiology and Therapeutic Radiology Committee of the PLA

1991: Second Prize of the Military Science and Technology Progress Award

1992–2008: Group Leader of the Group of Intervention of Chinese Journal of Radiology

1992–2015: Standing Editorial Board Member and Editorial Board Member of Journal of Interventional Radiology

1993: Granted the Lifetime Special Government Allowance of the State Council

1993–2012: Deputy Chief Editor of Chinese Journal of Medical Image Technology

1994: Third Prize of the Military Science and Technology Progress Award

1997: Second Prize of the Military Science and Technology Progress Award

1997–2009: Standing Member of Chinese Society of Radiology

1999: Third Prize of the Military Science and Technology Progress Award

1999–2010: Deputy Director Member of Chinese Society of Interventional Oncology

2002: Second Prize of the Military Science and Technology Progress Award

2005: Third Prize of the Military Science and Technology Progress Award

Member of Radiological Society of North America(RSNA)

Standing Member of Chinese Society of Radiology

Group Leader of the Group of Intervention of Chinese Journal of Radiology

Deputy Director Member of Chinese Society of Interventional Oncology

Director Member of Beijing Medical Association Society of Interventional Radiology

Deputy Chief Editor of Chinese Journal of Medical Image Technology

Standing Member of Professional Committee of Radiological Medicine of the Chinese People’s Liberation Army

Standing Editorial Board Member and Editorial Board Member of Journal of Interventional Radiology

Awarded the Special Government Allowance of the State Council

Awarded three Second Prizes and four Third Prizes for Military Science and Technology Progress.

Awarded the honorary title of “Chinese College of Interventionalists(CCI) Master Interventionalist”

Led multiple national and provincial/ministerial scientific research projects, including two projects funded by the National Natural Science Foundation of China and two projects funded by the Department of Science and Technology of Sichuan Province.

In the pioneering development of interventional medicine in China, Zhang Jinshan has been an indispensable founder and leading figure. As China’s first overseas-trained doctoral graduate in radiological medicine, he returned to China in the 1980s after completing his studies abroad and introduced cutting-edge international interventional technologies to the country. Over more than four decades of dedicated practice and research, he has helped propel Chinese interventional medicine from its infancy to a position at the forefront of the global field through his exceptional clinical expertise and profound academic accomplishments.

Professor Zhang Jinshan has long been dedicated to the field of medical imaging and has developed distinctive expertise in selective and superselective interventional diagnosis and treatment for solid tumors such as liver cancer, demonstrating exceptional technical proficiency and profound academic accomplishment. Beginning in the 1990s, he led his team in pioneering the clinical application and research of TIPSS and B-ORTO in China, filling major gaps in the domestic field and opening new paths for the interventional management of gastrointestinal bleeding caused by portal hypertension secondary to liver cirrhosis. In addition, he has made groundbreaking contributions to the interventional diagnosis and treatment of peripheral vascular diseases, as well as to preoperative embolization for spinal tumors.

In the field of liver cancer treatment, Professor Zhang Jinshan not only led the development of standardized treatment protocols for liver cancer but also pioneered Transcatheter Arterial Chemoembolization with temporary Hepatic Vein Thrombosis (TACE-THVO) for primary liver cancer, bringing the efficacy of interventional therapy to a new level. In recognition of his outstanding clinical and scientific contributions, he was awarded the honorary title of “Chinese Master of Interventional Radiology” at the 2019 annual conference of the Chinese College of Interventionalists.

Professor Zhang Jinshan is not only a master clinician but also a driving force in the development of the discipline and a dedicated mentor in talent cultivation. He led his team in establishing one of China’s premier interventional therapy centers. As a doctoral supervisor, he has trained a large number of outstanding specialists and future leaders in interventional medicine, with many of his students and protégés now serving across the country. Academically, he has led multiple key national and military research projects, published more than 300 academic papers, and served as chief editor of three monographs, making remarkable contributions to the establishment of China’s academic framework for interventional medicine and the nationwide dissemination of its technologies.

From the laboratory to the operating room, and from academic podiums to grassroots hospitals, Professor Zhang Jinshan has consistently upheld the principles of “pioneering, innovation, pragmatism, and compassion". He has devoted his life to fulfilling the mission of a physician—relieving patients’ suffering through minimally invasive techniques and advancing the discipline through academic excellence—thereby establishing himself as a truly towering figure and one of the foremost authorities in the field of interventional medicine in China.

Professor Zhang Jinshan’s Academic Achievements

Professor Zhang Jinshan has achieved prolific academic accomplishments, having published over 300 academic papers covering areas such as interventional therapy for liver cancer, minimally invasive treatment of portal hypertension, interventional treatment of vascular diseases, and tumor ablation.

Selected Publications by Professor Zhang Jinshan

1. Zhang Jinshan, Wang Maoqiang. Experiments and Clinical Studies of transjugular intrahepatic portosystemic stent shunt (TIPSS). Chinese Journal of Radiology, 1993，27（6）：361-365.

Professor Zhang Jinshan is the first author. This is one of the early research papers in China that systematically elaborates on the TIPSS technique. Through animal experiments and clinical case analysis, it confirmed that TIPSS is a safe and effective minimally invasive method for treating portal hypertension and its complications, laying an important foundation for the promotion and application of this technique in China.

2.Zhang Jinshan, Li Huai. Clinical study on transcatheter arterial embolization with temporary hepatic vein occlusion for the treatment of primary liver cancer.Chinese Journal of Radiology, 1996，30（8）：521-524.

Professor Zhang Jinshan is the first author. He innovatively proposed the technique of "transcatheter arterial embolization with temporary hepatic vein occlusion." Clinical results demonstrated that this method can significantly increase the drug concentration within liver cancer lesions, reduce damage to normal liver tissue, and effectively improve the therapeutic outcomes for intermediate and advanced liver cancer, providing a novel strategy for the interventional treatment of liver cancer.

3. Zhang Jinshan, Wang Maoqiang, Li Huai. Interventional treatment of Budd-Chiari syndrome. Chinese Journal of Medical Imaging Technology, 1998，14（3）：189-191.

Professor Zhang Jinshan is the first author. This paper systematically summarizes the early experience in interventional treatment of Budd-Chiari syndrome in China, elaborating in detail on the key operational points and therapeutic efficacy of techniques such as percutaneous transluminal angioplasty and stent placement. It confirms that interventional therapy is the preferred minimally invasive method for Budd-Chiari syndrome, promoting the standardized development of treatment for this disease.

4.Zhang Jinshan, Li Huai, Wang Maoqiang. Clinical value of superselective hepatic arterial chemoembolization in the treatment of hypovascular liver cancer. Chinese Journal of Radiology, 2000，34（5）：335-337.

Professor Zhang Jinshan is the first author. Addressing the challenges in interventional treatment of hypovascular liver cancer, this paper explores the clinical efficacy of superselective hepatic arterial chemoembolization. The results indicate that this technique can precisely target the lesions and improve the treatment response rate, providing an important clinical basis for the interventional treatment of hypovascular liver cancer.

5. Zhang Jinshan, Li Huai, Wang Maoqiang. Interventional treatment of peripheral vascular stenosis and occlusion.Chinese Journal of Radiology, 2002，36（7）：612-614.

Professor Zhang Jinshan is the first author. This paper summarizes the interventional treatment experience of over 400 patients with peripheral vascular stenosis and occlusion, analyzing the indications and efficacy of techniques such as balloon angioplasty and stent placement. It confirms that interventional therapy is a safe and effective approach for peripheral vascular diseases, providing practical support for its clinical promotion.

6.Zhang Jinshan, Li Huai, Wang Maoqiang. Clinical application of CT-guided percutaneous puncture ablation in the treatment of abdominal tumors. Chinese Journal of Medical Imaging Technology, 2004，20（9）：1395-1397.

Professor Zhang Jinshan is the first author. This paper explores the application value of CT-guided percutaneous puncture techniques such as radiofrequency ablation and chemical ablation in the treatment of abdominal tumors. The clinical results show that this method is minimally invasive with reliable efficacy, offering a minimally invasive treatment option for patients with inoperable abdominal tumors.

7.Zhang Jinshan, Wang Maoqiang, Li Huai. Advances in the application of interventional therapy for benign prostatic hyperplasia. Chinese Journal of Radiology, 2006，40（8）：876-878.

Professor Zhang Jinshan is the corresponding author. This paper systematically reviews the cutting-edge advances in interventional therapy for benign prostatic hyperplasia, including the principles, procedures, and efficacy of techniques such as prostatic artery embolization and stent placement, providing new insights for the minimally invasive treatment of benign prostatic hyperplasia.

8.Zhang Jinshan, Li Huai, Wang Maoqiang. Discussion on the standardization of interventional therapy for liver cancer. Chinese Journal of Practical Surgery, 2008，28（10）：856-858.

Professor Zhang Jinshan is the corresponding author. Drawing on years of clinical experience and research findings, he led the discussion on standardized protocols for interventional therapy of liver cancer, covering key aspects such as preoperative assessment, treatment modality selection, and postoperative management, providing important references for the formulation of clinical guidelines for interventional therapy of liver cancer in China.

Professor Zhang Jinshan co-authored monographs

1. Interventional Radiology (People's Military Medical Press, 1995): The first monograph in China to systematically discuss the theories and techniques of interventional radiology. It comprehensively elaborates on the interventional diagnosis and treatment system for tumors, vascular diseases, and non-vascular diseases, becoming a classic essential textbook for interventional physicians in China.

2.Interventional Therapy for Liver Cancer (People's Health Press, 2001): Focusing on minimally invasive interventions for liver cancer, this book systematically summarizes techniques such as TACE, ablation, and vascular intervention, refines operational standards and the prevention and management of complications, and promotes the standardization of interventional therapy for liver cancer.

3.Interventional Treatment of Portal Hypertension (Science Press, 2005): This book systematically elaborates on minimally invasive techniques for portal hypertension, such as TIPSS and B-ORTO, covering experimental research, clinical procedures, long-term follow-up, and efficacy evaluation, filling the gap in monographs on interventional treatment of portal hypertension in China.

Professor Zhang Jinshan’s Research project

1.The National "Eighth Five-Year Plan" Scientific and Technological Key Project—Clinical and Basic Research on Comprehensive Interventional Therapy for Liver Cancer (Project Leader): This project systematically explored multimodal interventional strategies for liver cancer, established the core regimen of superselective TACE combined with local ablation, and significantly improved the therapeutic outcomes for intermediate and advanced liver cancer.

2.The Military "Ninth Five-Year Plan" Key Medical Scientific Research Project—Standardized Research on TIPSS for the Treatment of Portal Hypertension (Project Leader): This project formulated China's first operational standards and postoperative management guidelines for TIPSS, reduced the incidence of complications, and promoted the popularization of this technique throughout the military and across the country.

3.National Natural Science Foundation of China Project — Research on the Mechanism of Targeted Therapy for Liver Cancer Using Hepatic Vein Occlusion Combined with Chemoembolization (Project Leader): This project revealed the synergistic enhancement mechanisms of the innovative technique at the levels of hemodynamics, drug metabolism, and the tumor microenvironment, providing theoretical support for precision interventional therapy of liver cancer.

4.Military Clinical High-Tech Major Project-Establishment and Clinical Application of the Interventional Treatment Technology System for Complex Vascular Diseases (Project Leader): This project overcame interventional challenges in complex lesions such as Budd-Chiari syndrome, peripheral vascular occlusion, and vascular malformations, forming a complete technical system that has been promoted and applied widely.

Dr. Premkamol Patraithikul is a general surgeon with advanced training in minimally invasive techniques. Dr. Patraithikul earned an M.D. from Khon Kaen University. Dr. Patraithikul completed a residency in general surgery at Thammasat University. Dr. Patraithikul completed a fellowship in laparoscopic surgery at Mahidol University (Siriraj Hospital) in Thailand.

Clinical expertise includes laparoscopic and robotic surgery. Practice also covers general surgery, obesity and weight‑management surgery, and surgery for gastrointestinal conditions.

Dr. Shute Ailia DAE is an experienced Medical Oncology Specialist currently practicing at Optimed International Çorlu Hospital.

Education: Graduated from Dokuz Eylül University Faculty of Medicine (2013), completed her Internal Medicine specialization at Bezmialem Vakıf University Hospital (2018), and her Hematology and Oncology subspecialty at Başkent University Hospital (2023).

Experience: Served as an Internal Medicine Specialist at Bezmialem Vakıf University Hospital (2018–2020) and as a Medical Oncology Instructor at Başkent University Adana Dr. Turgut Noyan Practice and Research Center (2023–2024), before joining Optimed International Çorlu Hospital.

Core Expertise: Breast cancer, lung cancer, prostate cancer, gastrointestinal cancers (colon, stomach, esophagus, pancreas, liver), lymphomas, melanoma, gynecological cancers, and genitourinary cancers.

Languages: English, Turkish, and Swahili.

Dr. DAE combines his strong academic and research background with extensive clinical expertise to deliver advanced, comprehensive care to his patients.

Professor Park Jung-won is a leading Korean specialist in hepatocellular carcinoma with over 30 years of experience. He is the Director of the Liver and Liver Cancer Center and the Integrated Cancer Care Center at Myongji Hospital. He led Korea’s first HCC guidelines in 2003. He has also overseen their updates for about 20 years. His team validated proton beam radiotherapy for liver cancer, as published in the Journal of Hepatology. He has authored more than 200 SCI-indexed papers. He also helped lead global trials, including the 2025 CheckMate 9DW study, which showed improved outcomes with nivolumab plus ipilimumab for unresectable HCC.

MD/PhD, Seoul National University; Member, National Academy of Medicine of Korea; former President, Korean Liver Cancer Association; Chair, Korean HCC Guidelines Committee; Prime Minister’s and Health Minister’s commendations; Pfizer Medical Research Award and Roche Oncology Academic Award.

Dr. Zulfu Sertkaya is an associate professor and andrologist at Andro Expertise in Istanbul. He holds the FEBU title from the European Association of Urology. Dr. Sertkaya focuses on male health, sexual function, and aesthetic urological procedures. He treats patients at his clinic and performs surgeries at affiliated hospitals.

• Earned Fellow of the European Board of Urology (FEBU) status.
• Specialize in andrology, male sexual health, and aesthetic urology.
• Performs penile implant surgery and varicocelectomy for infertility.
• Works at a clinic accredited by the Turkish Medical Association.

Dr. Yilmaz Bilgic is a gastroenterologist at the JCI-accredited Medipol Acibadem District Hospital in Istanbul. He specializes in the treatment of Crohn's disease, ulcerative colitis, and complex liver disorders. Dr. Bilgic completed specialized endoscopy training at Anam Hospital in South Korea. He also finished a training course on ERCP at the Olympus Training Center in Germany.

• Performs diagnostic and therapeutic endoscopy, colonoscopy, and stomach resection.
• Treats gastrointestinal conditions including Barrett's esophagus and chronic pancreatitis.
• Served as Assistant Chief Physician at Inonu University Turgut Ozal Medical Center.
• Maintains a Google Scholar H-index of 10 for his research in gastroenterology.

Dr. Cemalettin Aydin is a professor of general surgery at Medipol Acibadem District Hospital in Istanbul. He specializes in gastroenterology surgery and complex weight loss procedures. He completed a prestigious fellowship in gastroenterology surgery at the Türkiye High Specialization Hospital.

• Performs advanced bariatric surgeries including gastric bypass and sleeve gastrectomy.
• Treats complex gastrointestinal conditions such as pancreatitis, Crohn's disease, and cirrhosis.
• Expert in endoscopic sleeve gastroplasty (ESG) and laparoscopic anti-reflux surgery.
• Works at Medipol Acibadem, a JCI-accredited facility using the da Vinci robotic system.